The role of stimulant washout status in functional connectivity of default mode and fronto-parietal networks in children with neurodevelopmental conditions.

Autism, Attention Deficit Hyperactivity Disorder (ADHD), Functional Connectivity (FC) Stimulant Medication Washout

Journal

Research in developmental disabilities
ISSN: 1873-3379
Titre abrégé: Res Dev Disabil
Pays: United States
ID NLM: 8709782

Informations de publication

Date de publication:
09 Feb 2024
Historique:
received: 28 04 2023
revised: 22 01 2024
accepted: 24 01 2024
medline: 11 2 2024
pubmed: 11 2 2024
entrez: 10 2 2024
Statut: aheadofprint

Résumé

Stimulant medication is the primary pharmacological treatment for attention dysregulation and is commonly prescribed for children with Attention-Deficit/Hyperactivity Disorder (ADHD) and Autism. Neuroimaging studies of these groups commonly use a 24-48-hour washout period to mediate the effects of stimulant medication on functional connectivity (FC) metrics. However, the impact of washout on functional connectivity has received limited study. We used fMRI data from participants with diagnosis of Autism and ADHD (and an off stimulant control) from the Adolescent Brain and Cognitive Development (ABCD) and Autism Brain Imaging Data Exchange (ABIDE) databases to explore the effect of simulant washout on FC. Connectivity within and between the default mode (DMN) and fronto-parietal networks (FPN) was examined, as these networks have previously been implicated in attention dysregulation and associated with stimulant medication usage. For each diagnostic group, we assessed effects in interconnectivity between DMN and FPN, intraconnectivity within DMN, and intraconnectivity within FPN. We found no significant effect of medication status in intra- and inter-connectivity of the DMN and the FPN in either diagnostic group. Our findings suggest that more information is needed about the effect of stimulant medication, and washout, on the FC of attention networks in clinical populations.

Sections du résumé

BACKGROUND BACKGROUND
Stimulant medication is the primary pharmacological treatment for attention dysregulation and is commonly prescribed for children with Attention-Deficit/Hyperactivity Disorder (ADHD) and Autism. Neuroimaging studies of these groups commonly use a 24-48-hour washout period to mediate the effects of stimulant medication on functional connectivity (FC) metrics. However, the impact of washout on functional connectivity has received limited study.
METHODS METHODS
We used fMRI data from participants with diagnosis of Autism and ADHD (and an off stimulant control) from the Adolescent Brain and Cognitive Development (ABCD) and Autism Brain Imaging Data Exchange (ABIDE) databases to explore the effect of simulant washout on FC. Connectivity within and between the default mode (DMN) and fronto-parietal networks (FPN) was examined, as these networks have previously been implicated in attention dysregulation and associated with stimulant medication usage. For each diagnostic group, we assessed effects in interconnectivity between DMN and FPN, intraconnectivity within DMN, and intraconnectivity within FPN.
RESULTS RESULTS
We found no significant effect of medication status in intra- and inter-connectivity of the DMN and the FPN in either diagnostic group.
IMPLICATIONS CONCLUSIONS
Our findings suggest that more information is needed about the effect of stimulant medication, and washout, on the FC of attention networks in clinical populations.

Identifiants

pubmed: 38340416
pii: S0891-4222(24)00023-4
doi: 10.1016/j.ridd.2024.104691
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104691

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Kelsey Harkness (K)

Department of Graduate Studies, University of Calgary, Canada; Hotchkiss Brain Institute, Cumming School of Medicine, Canada; Alberta Children's Hospital Research Institute, Canada. Electronic address: kelsey.harkness@ucalgary.ca.

Signe Bray (S)

Hotchkiss Brain Institute, Cumming School of Medicine, Canada; Alberta Children's Hospital Research Institute, Canada; Cumming School of Medicine, University of Calgary, Canada.

Kara Murias (K)

Hotchkiss Brain Institute, Cumming School of Medicine, Canada; Alberta Children's Hospital Research Institute, Canada; Cumming School of Medicine, University of Calgary, Canada.

Classifications MeSH